Extract: High passage Cendehill strain of rubella virus, possesing in vivo and in vitro characteristics of an attenuated virus, was tested for efficacy in 28 seronegative infants, 3 to 23 months old.
CAMBRIDGE, Mass. & BRISBANE, Australia--(BUSINESS WIRE)--Vaxxas, a biotechnology company commercializing a novel vaccination platform, today announced that it has received a US$5 million [AU$7.5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results